Suicide not associated with efavirenz use in the D:A:D cohort study
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Conference reports
Gender differences in use of cardiovascular disease-related interventions: D:A:D study
1 December 2014. Related: Conference reports, Treatment strategies, Women's health, Side effects.
Efavirenz decreases exposure to hormonal contraceptive implant
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Increased risk of ART-related hepatotoxicity in HIV positive pregnant women
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Side effects.
Darunavir pharmacokinetics in pregnancy and postpartum
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
BHIVA Autumn Conference, 9-10 October 2014, London
1 December 2014. Related: Conference reports.
Good management of HIV positive pregnant women in UK – with some room for improvement
1 December 2014. Related: Conference reports, Pregnancy.
Southern African Clinicians Society Conference, 24-27 September 2014, Cape Town, South Africa
1 December 2014. Related: Conference reports.
Efavirenz-associated gynaecomastia reported to the national HIV and TB healthcare workers hotline in South Africa
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Infants start ART too late but improvement over time in Southern Africa
1 December 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Treatment outcomes in HIV positive and negative people with drug resistant TB in Khayelitsha, Cape Town
1 December 2014. Related: Conference reports, TB coinfection.
Pregnancy a risk factor for poor antiretroviral treatment outcomes in South African adolescents
1 December 2014. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 5-9 September 2014, Washington, DC
1 October 2014. Related: Conference reports.
Antiretroviral studies at ICAAC 2014: darunavir-based FDC with TAF, cobicistat, doravirine, Stribild and gel formulation PrEP
1 October 2014. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Switch from efavirenz to rilpivirine quells CNS toxicity, improves sleep
1 October 2014. Related: Conference reports, Antiretrovirals.
HIV persists in lung macrophages of people on suppressive ART
1 October 2014. Related: Conference reports, Antiretrovirals, Cure-related research.
Only 10% of veterans with HCV or HCV/HIV in the US treated for HCV
1 October 2014. Related: Conference reports, Hepatitis coinfection.
20th International AIDS Conference, 20-25 July 2014, Melbourne
1 October 2014. Related: Conference reports.
Update on baseline STIs in UK oral PrEP study (PROUD)
1 October 2014. Related: Conference reports, HIV prevention and transmission.
High prevalence of COPD at baseline in START study sub-study
1 October 2014. Related: Conference reports, Coinfections and complications.
Risk of CVD or type-2 diabetes according to change in BMI after starting ART
1 October 2014. Related: Conference reports, Antiretrovirals, Side effects.
Rosuvastatin may be partially effective in moderating residual immune activation on ART
1 October 2014. Related: Conference reports, Side effects.
Reasons for loss to follow up in the Malawi Option B+ programme
1 October 2014. Related: Conference reports, Pregnancy.
20th International AIDS Conference, 20-25 July 2014, Melbourne
1 August 2014. Related: Conference reports.
The loss of friends and colleagues from flight MH 17
1 August 2014. Related: Conference reports.
Higher ART coverage is associated with lower HIV infection rates in a multi-country analysis
1 August 2014. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Pill A, Pill B: simplified second-line treatment for low-income countries
1 August 2014. Related: Conference reports, Antiretrovirals, Treatment access.
UNAIDS sets 90-90-90 target for 2020 to end AIDS by 2030
1 August 2014. Related: Conference reports, Treatment access.
No difference in overall anaemia rate with reduced dose AZT
1 August 2014. Related: Conference reports, Treatment strategies, Treatment access.
Open label oral PrEP at four doses a week: why zero infections does not equal 100% efficacy
1 August 2014. Related: Conference reports, HIV prevention and transmission.
Cure research at IAS 2014: TILDA measures the reservoir and romidepsin wakes it up
1 August 2014. Related: Conference reports, Cure-related research.
HIV and transgender issues at AIDS 2014
1 August 2014. Related: Conference reports.
Transgender services and clinics: interviews at AIDS 2014 with JoAnne Keatley and Beatriz Grinsztejn
1 August 2014. Related: Conference reports, Activism & advocacy.
Publications launched at AIDS 2014
1 August 2014. Related: Conference reports.
6th International Workshop on HIV Paediatrics, 18-19 July 2014, Melbourne
1 August 2014. Related: Conference reports.
Update on paediatric antiretrovirals
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Is d4T a viable option for children in low-income countries?
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
3TC or FTC monotherapy suboptimal as a bridging strategy for adolescents
1 August 2014. Related: Conference reports, Paediatric care.
Rationalising the paediatric antiretroviral formulary in Malawi
1 August 2014. Related: Conference reports, Treatment access, Paediatric care.
Time to first-line failure in the IeDEA cohort
1 August 2014. Related: Conference reports, Paediatric care.
Influence of early ART on antibody detection in children
1 August 2014. Related: Conference reports, Paediatric care.
8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-Poor Settings (INTEREST), 5-6 May 2014, Lusaka, Zambia
1 August 2014. Related: Conference reports.
Short-term safety of atazanavir/ritonavir-based second line treatment in Zambia
1 August 2014. Related: Conference reports, Antiretrovirals.
Pregnancy outcomes in Zambia
1 August 2014. Related: Conference reports, Pregnancy.
Uptake of ART is influenced by distance to the health facility in rural Zambia
1 August 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Genotyping using dried blood spots in rural South African setting
1 August 2014. Related: Conference reports, Drug resistance.
49th Annual Meeting of the European Association for the Study of the Liver (EASL 2014), 9-13 April 2014, London
27 May 2014. Related: Conference reports.
Activists protest the price of sofosbuvir: “So-Valdi, So-Expensive” – UK access already rationed
27 May 2014. Related: Conference reports, Treatment access.
EASL 2014: summary of interferon-free HCV studies with new DAAs
27 May 2014. Related: Conference reports, Other news.
WHO launch treatment guidelines for hepatitis C (2014)
27 May 2014. Related: Conference reports, Guidelines, Hepatitis coinfection.
3rd Joint Conference of BHIVA/BASHH, 1-4 April 2014, Liverpool
27 May 2014. Related: Conference reports.
50% of UK seroconverters start ART within 1.4 years of infection: treating during primary infection should be a patient choice
27 May 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
PIVOT study: further analysis from five-year PI/r monotherapy strategy study
27 May 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Sexually transmitted HCV in HIV positive and negative gay men
27 May 2014. Related: Conference reports, Hepatitis coinfection.
Annual HCV testing and use of core antigen to reduce costs and increase diagnosis during acute HCV
27 May 2014. Related: Conference reports, Hepatitis coinfection.
HIV positive attitudes to involvement as donors and recipients in organ transplant programmes
27 May 2014. Related: Conference reports.
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
27 May 2014. Related: Conference reports.
Pharmacokinetics of antiretrovirals in pregnancy
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Better virologic outcomes with efavirenz vs lopinavir/ritonavir in pregnant women and no difference in risk of preterm birth
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Once daily lopinavir/ritonavir not recommended for routine use in children and adolescents
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Early antiretroviral treatment in infants
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Hospitalisation among elite controllers
27 May 2014. Related: Conference reports, Treatment strategies.
Catching up with pathogenesis and cure research from CROI 2014
27 May 2014. Related: Conference reports, Paediatric care, Cure-related research.
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
24 March 2014. Related: Conference reports.
No HIV transmissions with undetectable viral load: interim PARTNER study results show need for longer follow-up
24 March 2014. Related: Conference reports, HIV prevention and transmission.